Cargando…
Virological and clinical rebounds of COVID-19 soon after nirmatrelvir/ritonavir discontinuation
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250152/ https://www.ncbi.nlm.nih.gov/pubmed/35792281 http://dx.doi.org/10.1016/j.cmi.2022.06.029 |
| _version_ | 1784739745810612224 |
|---|---|
| author | Antonelli, Guido Focosi, Daniele Turriziani, Ombretta Tuccori, Marco Brandi, Rossella Fillo, Silvia Ajassa, Camilla Lista, Florigio Mastroianni, Claudio M. |
| author_facet | Antonelli, Guido Focosi, Daniele Turriziani, Ombretta Tuccori, Marco Brandi, Rossella Fillo, Silvia Ajassa, Camilla Lista, Florigio Mastroianni, Claudio M. |
| author_sort | Antonelli, Guido |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9250152 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92501522022-07-05 Virological and clinical rebounds of COVID-19 soon after nirmatrelvir/ritonavir discontinuation Antonelli, Guido Focosi, Daniele Turriziani, Ombretta Tuccori, Marco Brandi, Rossella Fillo, Silvia Ajassa, Camilla Lista, Florigio Mastroianni, Claudio M. Clin Microbiol Infect Letter to the Editor European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022-12 2022-07-02 /pmc/articles/PMC9250152/ /pubmed/35792281 http://dx.doi.org/10.1016/j.cmi.2022.06.029 Text en © 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Antonelli, Guido Focosi, Daniele Turriziani, Ombretta Tuccori, Marco Brandi, Rossella Fillo, Silvia Ajassa, Camilla Lista, Florigio Mastroianni, Claudio M. Virological and clinical rebounds of COVID-19 soon after nirmatrelvir/ritonavir discontinuation |
| title | Virological and clinical rebounds of COVID-19 soon after nirmatrelvir/ritonavir discontinuation |
| title_full | Virological and clinical rebounds of COVID-19 soon after nirmatrelvir/ritonavir discontinuation |
| title_fullStr | Virological and clinical rebounds of COVID-19 soon after nirmatrelvir/ritonavir discontinuation |
| title_full_unstemmed | Virological and clinical rebounds of COVID-19 soon after nirmatrelvir/ritonavir discontinuation |
| title_short | Virological and clinical rebounds of COVID-19 soon after nirmatrelvir/ritonavir discontinuation |
| title_sort | virological and clinical rebounds of covid-19 soon after nirmatrelvir/ritonavir discontinuation |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250152/ https://www.ncbi.nlm.nih.gov/pubmed/35792281 http://dx.doi.org/10.1016/j.cmi.2022.06.029 |
| work_keys_str_mv | AT antonelliguido virologicalandclinicalreboundsofcovid19soonafternirmatrelvirritonavirdiscontinuation AT focosidaniele virologicalandclinicalreboundsofcovid19soonafternirmatrelvirritonavirdiscontinuation AT turrizianiombretta virologicalandclinicalreboundsofcovid19soonafternirmatrelvirritonavirdiscontinuation AT tuccorimarco virologicalandclinicalreboundsofcovid19soonafternirmatrelvirritonavirdiscontinuation AT brandirossella virologicalandclinicalreboundsofcovid19soonafternirmatrelvirritonavirdiscontinuation AT fillosilvia virologicalandclinicalreboundsofcovid19soonafternirmatrelvirritonavirdiscontinuation AT ajassacamilla virologicalandclinicalreboundsofcovid19soonafternirmatrelvirritonavirdiscontinuation AT listaflorigio virologicalandclinicalreboundsofcovid19soonafternirmatrelvirritonavirdiscontinuation AT mastroianniclaudiom virologicalandclinicalreboundsofcovid19soonafternirmatrelvirritonavirdiscontinuation |